Skip to content

ARAP3 Facilitates Glioma Progression via IGF2BP3-Mediated m6A Modification Stabilization

Aug 2026 · Cell Biochemistry and Biophysics · Vol 84, pp. 4435 - 4448 · 0 citations · 28 references
Medicine

TL;DR

ARAP3 promotes glioma progression and is sustained by IGF2BP3-mediated m6A-dependent mRNA stabilization, highlighting the IGF2BP3–ARAP3 axis as a potential biomarker and therapeutic target.

View source

Similar papers

Open access Oct 2026

LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis.

Gliomas, the most prevalent primary malignant brain tumors, are characterized by highly invasive growth patterns. Emerging evidence indicates that long non-coding RNAs are essential for regulating key oncogenic pathways. This study focuses on lncRNA LAMTOR5 antisense RNA AS1 (LAMTOR5-AS1, also known as SLC16A4-AS1), se...

Jia-Yi Li, Jing Li, Lin Yu · 0 citations
Oct 2026

METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression.

Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.

Meng-Ke Li, Yan Zhao, Yuan Li · 0 citations
Sep 2026

KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma.

Temozolomide (TMZ) resistance remains a major obstacle to effective glioblastoma (GBM) treatment and is closely linked to enhanced DNA damage repair. Kinesin family member 4A (KIF4A) has been implicated in tumor progression, but its role in TMZ resistance remains unclear. In this study, KIF4A and TAR DNA-binding protei...

Quan-Quan Guo, Wan-Ru Chen, Lin-Chun Wen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.